Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multicopy Targeted Integration for Accelerated Development of High-Producing Chinese Hamster Ovary Cells
Daria Sergeeva, Gyun Min Lee, Lars K. Nielsen, et al.
ACS Synthetic Biology (2020) Vol. 9, Iss. 9, pp. 2546-2561
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Assessing developability early in the discovery process for novel biologics
Monica L. Fernández‐Quintero, Anne Ljungars, Franz Waibl, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 42
Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells
Zhengmei Li, Zhenlin Fan, Xiao-Yin Wang, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 38
A Flexible Hybrid Site‐Specific Integration‐Based Expression System in CHO Cells for Higher‐Throughput Evaluation of Monoclonal Antibody Expression Cassettes
Alana C. Szkodny, Kelvin H. Lee
Biotechnology Journal (2025) Vol. 20, Iss. 1
Open Access
Gene copy number, gene configuration and LC/HC mRNA ratio impact on antibody productivity and product quality in targeted integration CHO cell lines
Zion Lee, Jun Wan, Amy Shen, et al.
Biotechnology Progress (2024) Vol. 40, Iss. 3
Closed Access | Times Cited: 5
The new frontier in CHO cell line development: From random to targeted transgene integration technologies
Nikolas Zeh, Moritz J. Schmidt, Patrick Schulz, et al.
Biotechnology Advances (2024) Vol. 75, pp. 108402-108402
Open Access | Times Cited: 5
Factors affecting the quality of therapeutic proteins in recombinant Chinese hamster ovary cell culture
Tae Kwang Ha, Dong‐Il Kim, Che Lin Kim, et al.
Biotechnology Advances (2021) Vol. 54, pp. 107831-107831
Closed Access | Times Cited: 37
Development of a targeted integration Chinese hamster ovary host directly targeting either one or two vectors simultaneously to a single locus using the Cre/Lox recombinase‐mediated cassette exchange system
Domingos Ng, Meixia Zhou, Dejin Zhan, et al.
Biotechnology Progress (2021)
Closed Access | Times Cited: 31
Improving recombinant protein production in CHO cells using the CRISPR-Cas system
Ali Kerem Kalkan, Fahreddin Palaz, Sofija Semeniuk, et al.
Biotechnology Advances (2023) Vol. 64, pp. 108115-108115
Open Access | Times Cited: 11
Recent advances in generative biology for biotherapeutic discovery
Marissa Mock, Christopher J. Langmead, Peter Grandsard, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 3, pp. 255-267
Open Access | Times Cited: 3
How to train your cell - Towards controlling phenotypes by harnessing the epigenome of Chinese hamster ovary production cell lines
Nicolas Marx, Peter Eisenhut, Marcus Weinguny, et al.
Biotechnology Advances (2022) Vol. 56, pp. 107924-107924
Open Access | Times Cited: 19
Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones
Wenwen Yang, Junhe Zhang, Yunxi Xiao, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 18
Manipulating gene expression levels in mammalian cell factories: An outline of synthetic molecular toolboxes to achieve multiplexed control
Peter Eisenhut, Nicolas Marx, Giulia Borsi, et al.
New Biotechnology (2023) Vol. 79, pp. 1-19
Open Access | Times Cited: 10
CRISPR‐interceded CHO cell line development approaches
Shahin Amiri, Setare Adibzadeh, Samaneh Ghanbari, et al.
Biotechnology and Bioengineering (2023) Vol. 120, Iss. 4, pp. 865-902
Closed Access | Times Cited: 9
CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering
Katja Glinšek, Krištof Bozovičar, Tomaž Bratkovič
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8144-8144
Open Access | Times Cited: 9
An optimized genome-wide, virus-free CRISPR screen for mammalian cells
Kai Xiong, Karen Julie la Cour Karottki, Hooman Hefzi, et al.
Cell Reports Methods (2021) Vol. 1, Iss. 4, pp. 100062-100062
Open Access | Times Cited: 24
Expanding the CRISPR toolbox for Chinese hamster ovary cells with comprehensive tools for Mad7 genome editing
Johan Rojek, Yogesh Basavaraju, Saranya Nallapareddy, et al.
Biotechnology and Bioengineering (2023) Vol. 120, Iss. 6, pp. 1478-1491
Open Access | Times Cited: 7
Nanopore Cas9‐targeted sequencing enables accurate and simultaneous identification of transgene integration sites, their structure and epigenetic status in recombinant Chinese hamster ovary cells
Klaus Leitner, Krishna Motheramgari, Nicole Borth, et al.
Biotechnology and Bioengineering (2023) Vol. 120, Iss. 9, pp. 2403-2418
Open Access | Times Cited: 6
High‐efficiency and multilocus targeted integration in CHO cells using CRISPR‐mediated donor nicking and DNA repair inhibitors
Nathaniel K. Hamaker, Kelvin H. Lee
Biotechnology and Bioengineering (2023) Vol. 120, Iss. 9, pp. 2419-2440
Open Access | Times Cited: 6
Improving the secretory capacity of CHO producer cells: The effect of controlled Blimp1 expression, a master transcription factor for plasma cells
Su Hyun Kim, Minhye Baek, Sung-Je Park, et al.
Metabolic Engineering (2021) Vol. 69, pp. 73-86
Closed Access | Times Cited: 16
Streamlined Human Cell-Based Recombinase-Mediated Cassette Exchange Platform Enables Multigene Expression for the Production of Therapeutic Proteins
Seunghyeon Shin, Su Hyun Kim, Jae Seong Lee, et al.
ACS Synthetic Biology (2021) Vol. 10, Iss. 7, pp. 1715-1727
Closed Access | Times Cited: 15
Identification of hyperosmotic stress-responsive genes in Chinese hamster ovary cells via genome-wide virus-free CRISPR/Cas9 screening
Su Hyun Kim, Seunghyeon Shin, Minhye Baek, et al.
Metabolic Engineering (2023) Vol. 80, pp. 66-77
Open Access | Times Cited: 5
A high‐fidelity, dual site‐specific integration system in CHO cells by a Bxb1 recombinase
Yifeng Xu, Kerstin B. Crowe, Paulena L. Lieske, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 1
SiMPl‐GS: Advancing Cell Line Development via Synthetic Selection Marker for Next‐Generation Biopharmaceutical Production
Chansik Yoon, Eun‐ji Lee, Dong‐Il Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 1
A Precise and Sustainable Doxycycline-Inducible Cell Line Development Platform for Reliable Mammalian Cell Engineering with Gain-of-Function Mutations
Sung Wook Shin, Honggi Min, Jiwon Kim, et al.
Metabolic Engineering (2024) Vol. 86, pp. 12-28
Open Access | Times Cited: 1
Single‐Batch Expression of an Experimental Recombinant Snakebite Antivenom Based on an Oligoclonal Mixture of Human Monoclonal Antibodies
Anna Christina Adams, Lise Marie Grav, Shirin Ahmadi, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 10
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top